List of SBIR/STTR awards granted to IGE Therapeutics
IGE TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to IGE Therapeutics in June, 2016 for $2,258,938.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI122358-01 | Phase II | 2,258,938 | June 15, 2016 | |||||||
A SBIR Phase II contract was awarded to IGE Therapeutics in March, 2017 for $2,609,527.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI126680-01A1 | Phase II | 2,609,527 | March 1, 2017 | |||||||
A SBIR Phase I contract was awarded to IGE Therapeutics for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI082770-01 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to IGE Therapeutics for $552,946.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI054075-01 | Phase I | 552,946 | ||||||||
A SBIR Phase I contract was awarded to IGE Therapeutics for $803,683.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084348-01 | Phase I | 803,683 | ||||||||
A SBIR Phase I contract was awarded to IGE Therapeutics for $232,200.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 232,200 |
